PEPG NASDAQ
PepGen Inc.
1W: -6.3%
1M: +2.8%
3M: +97.3%
YTD: -58.4%
1Y: +112.9%
3Y: -50.6%
$2.98
-0.04 (-1.32%)
Weekly Expected Move ±8.0%
$3
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$206.1M
52W Range1.31-7.8
Volume682,484
Avg Volume893,997
Beta1.97
Dividend—
Analyst Ratings
Company Info
CEOJames McArthur
Employees57
SectorHealthcare
IndustryBiotechnology
IPO Date2022-05-06
Websitepepgen.com
321 Harrison Avenue
Boston, MA 02118
US
Boston, MA 02118
US
781-797-0979
About PepGen Inc.
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Latest News
BlackRock Inc. Buys Shares of 1,304,262 PepGen, Inc. $PEPG
ADAR1 Capital Management LLC Acquires New Shares in PepGen, Inc. $PEPG
PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
PepGen (PEPG) Upgraded to Buy: Here's What You Should Know
Catalyst Watch: Tesla talks AI5 chips, Intel reports, and the Warner Bros. deal goes to a vote
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Wyman Lisa | A-Award | 34,000 | $1.79 | 2026-06-18 |
| Resnick Joshua | A-Award | 34,000 | $1.79 | 2026-06-18 |
| Mayer Howard | A-Award | 34,000 | $1.79 | 2026-06-18 |
| Finer Mitchell H. | A-Award | 34,000 | $1.79 | 2026-06-18 |
| Dable Habib J | A-Award | 34,000 | $1.79 | 2026-06-18 |